ood morning, everyone, and how are you today? We are just fine, thank you, especially since we are on the road for a couple of days, holding furtive meetings with insightful contacts. While we will not forego needed cups of stimulation, this will mean only sporadic postings for a couple of days, although a few colleagues will cover the bases in our stead. That said, here are some items of interest to get you going. Hope your day is grand and, by all means, do stay in touch …

Amazon (AMZN) will not use pharmacy licenses it obtained from Tennessee and Indiana to sell prescriptions, but will sell medical devices and supplies instead, CNBC says. Jefferies analysts obtained documents through the Freedom of Information Act showing Amazon intends to sell medical devices and supplies in its Indiana fulfillment center, but not store or distribute prescription drugs. At least not right away.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy